<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6929455</article-id>
    <article-id pub-id-type="publisher-id">3260</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-019-3260-0</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>RCMF: a robust collaborative matrix factorization method to predict miRNA-disease associations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Cui</surname>
          <given-names>Zhen</given-names>
        </name>
        <address>
          <email>cuizhensdws@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Liu</surname>
          <given-names>Jin-Xing</given-names>
        </name>
        <address>
          <email>sdcavell@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gao</surname>
          <given-names>Ying-Lian</given-names>
        </name>
        <address>
          <email>yinliangao@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zheng</surname>
          <given-names>Chun-Hou</given-names>
        </name>
        <address>
          <email>zhengch99@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wang</surname>
          <given-names>Juan</given-names>
        </name>
        <address>
          <email>wangjuansdu@163.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0227 8151</institution-id><institution-id institution-id-type="GRID">grid.412638.a</institution-id><institution>School of Information Science and Engineering, </institution><institution>Qufu Normal University, </institution></institution-wrap>Rizhao, 276826 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0085 4987</institution-id><institution-id institution-id-type="GRID">grid.252245.6</institution-id><institution>Co-Innovation Center for Information Supply &amp; Assurance Technology, </institution><institution>Anhui University, </institution></institution-wrap>Hefei, 230601 China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0227 8151</institution-id><institution-id institution-id-type="GRID">grid.412638.a</institution-id><institution>Qufu Normal University Library, Qufu Normal University, </institution></institution-wrap>Rizhao, 276826 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>12</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>12</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>20</volume>
    <issue>Suppl 25</issue>
    <issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.</issue-sponsor>
    <elocation-id>686</elocation-id>
    <permissions>
      <copyright-statement>© The Author(s). 2019</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Predicting miRNA-disease associations (MDAs) is time-consuming and expensive. It is imminent to improve the accuracy of prediction results. So it is crucial to develop a novel computing technology to predict new MDAs. Although some existing methods can effectively predict novel MDAs, there are still some shortcomings. Especially when the disease matrix is processed, its sparsity is an important factor affecting the final results.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">A robust collaborative matrix factorization (RCMF) is proposed to predict novel MDAs. The L<sub>2,1</sub>-norm are introduced to our method to achieve the highest AUC value than other advanced methods.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">5-fold cross validation is used to evaluate our method, and simulation experiments are used to predict novel associations on Gold Standard Dataset. Finally, our prediction accuracy is better than other existing advanced methods. Therefore, our approach is effective and feasible in predicting novel MDAs.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>MiRNA-disease association prediction</kwd>
      <kwd>L<sub>2,1</sub>-norm</kwd>
      <kwd>Collaborative regularization</kwd>
      <kwd>Matrix factorization</kwd>
    </kwd-group>
    <conference xlink:href="http://ic-ic.tongji.edu.cn/2018/index.htm">
      <conf-name>2018 International Conference on Intelligent Computing (ICIC 2018) and Intelligent Computing and Biomedical Informatics (ICBI) 2018 conference</conf-name>
      <conf-loc>Wuhan and Shanghai, China</conf-loc>
      <conf-date>15-18 August 2018, 3-4 November 2018</conf-date>
    </conference>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2019</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par11">A short class of non-coding RNAs called miRNAs, whose length is generally 19 to 25 nt. They usually regulate gene expression and protein production [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]. Since the first two miRNAs lin-4 and let-7 were discovered in 1993 and 2000, respectively [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Thousands of miRNAs have been detected by biologists from nematodes to human eukaryotes [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. The latest miRNA database version miRBase contains 26,845 entries and more than 2000 human miRNAs are detected [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. It is worth noting that with the development of bioinformatics, more researchers are starting to focus on the function of miRNAs. In addition, miRNAs begin to play an important role in biological processes such as proliferation, cell differentiation, viral infection, and signal transduction [<xref ref-type="bibr" rid="CR15">15</xref>]. Moreover, some miRNAs are closely related to human diseases [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. For example, mir-433 will upregulate the expression of GRB2 in gastric cancer, which is a known tumor-associated protein [<xref ref-type="bibr" rid="CR19">19</xref>]. And in every pediatric brain tumor type, mir-25, mir-129, and mir-142 are differentially expressed [<xref ref-type="bibr" rid="CR20">20</xref>]. Considering the strong association between miRNA and disease, all their potential associations should be explored [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. In medicine, the advantage is that it can promote the diagnosis and treatment of some complex diseases [<xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR25">25</xref>]. However, predicting MDAs is time-consuming and expensive. Only a few novel associations are discovered and used in clinical medicine each year, and most of the associations are not be discovered by researchers. Therefore, it is imminent to improve the accuracy of prediction results.</p>
    <p id="Par12">In previous studies, functionally similar miRNAs always appear in similar diseases [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Based on such theory, more and more computational methods and models are proposed for identifying novel miRNA-disease associations (MDAs) [<xref ref-type="bibr" rid="CR13">13</xref>]. However, these methods have some shortcomings more or less. For example, Jiang et al. proposed an improved disease-gene prediction model [<xref ref-type="bibr" rid="CR28">28</xref>]. They introduced the principle and use of hypergeometric distribution. And then they analyzed the actual effect in the prediction model. Moreover, different datasets are used to predict novel MDAs, including the known human miRNA-disease data, miRNA functional similarity data and disease semantic similarity data. However, the shortcoming of this model is the excessive dependence on neighbor miRNA data. Chen et al. proposed a method HGIMDA (Heterogeneous Graph Inference miRNA-Disease Association) to predict novel MDAs [<xref ref-type="bibr" rid="CR29">29</xref>]. It is worth noting the known miRNA-disease associations, miRNA functional similarity, disease semantic similarity, and Gaussian interaction profile kernel similarity for diseases and miRNAs are integrated into this method. The benefit is that the accuracy of the algorithm is improved to some extent. The functional relationship between miRNA targets and disease genes in PPI (Protein–Protein Interaction) networks are considered by researchers. Shi et al. proposed a computational method to predict MDAs by performing random walk [<xref ref-type="bibr" rid="CR30">30</xref>]. They used PPIs, the miRNA-target interactions and disease-gene associations to identify potential MDAs. However, the model strongly depended on the miRNA-target interactions with high rate of false-positive and high false-negative results [<xref ref-type="bibr" rid="CR31">31</xref>]. Considering this disadvantage, Chen et al. proposed the RWRMDA (Random Walk with Restart for MiRNA-disease association) model [<xref ref-type="bibr" rid="CR32">32</xref>]. Their approach was to map all miRNAs to a miRNA functional similarity network. Then, random walk with restart method was implemented until they got stable probability [<xref ref-type="bibr" rid="CR33">33</xref>]. Finally, all candidate miRNAs will be sorted according to the probability of stability. Moreover, the method was the first global network-based method. Xuan et al. proposed a HDMP method [<xref ref-type="bibr" rid="CR34">34</xref>]. The mothed was based on weighted k-nearest-neighbors. The phenotype similarity and semantic similarity between diseases were used to calculate the miRNAs functional similarity matrix. However, the simple ranking of k-nearest-neighbors was not always reliable for prediction. So Chen et al. proposed a new method of ranking-based KNN called RKNNMDA to identify potential MDAs [<xref ref-type="bibr" rid="CR34">34</xref>]. These previously similarity-based sorted neighbors were re-ranked to get better prediction results. Recently, matrix factorization methods have been used to identify novel MDAs. The advantage is that these methods can better handle missing associations. Shen et al. proposed a matrix factorization model based collaborative matrix factorization to predict novel MDAs [<xref ref-type="bibr" rid="CR10">10</xref>]. Matrix factorization method takes one input matrix and tries to obtain two other matrices, then the two matrices are multiplied to approximate the input matrix. Gao et al. proposed a dual-network sparse graph regularized matrix factorization method (DNSGRMF) to predict novel MDAs and obtained better experimental results [<xref ref-type="bibr" rid="CR35">35</xref>]. However, this method does not necessarily solve the overfitting problem very well. Chen et al. developed a computational model of ELLPMDA (Ensemble Learning and Link Prediction for miRNA-Disease Association) to predict novel MDAs [<xref ref-type="bibr" rid="CR36">36</xref>]. The miRNA-disease association, miRNA functional similarity, disease semantic similarity and Gaussian profile kernel similarity for miRNAs and diseases were integrated, they used the integrated similarity network and utilized ensemble learning. Three classical algorithms based on similarity are combined to obtain better prediction results. However, even such an excellent method still has some shortcomings, such as excessive ensemble learning will bring more noise. Gao et al. proposed a Nearest Profile-based Collaborative Matrix Factorization (NPCMF) method to predict potential miRNA-disease associations [<xref ref-type="bibr" rid="CR37">37</xref>]. More importantly, this method has achieved the highest prediction accuracy so far.</p>
    <p id="Par13">In this paper, a simple yet effective matrix factorization model is proposed. Its main function is to predict new MDAs based on existing MDAs. Considering that the missing associations will have a negative impact on the predictions, a pre-processing step is used to solve this problem. The main purpose of this pre-processing method is to try to weight K nearest known neighbors (WKNKN) [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. It is worth noting that the L<sub>2,1</sub>-norm is introduced in the collaborative matrix factorization (CMF) method. And the L<sub>2,1</sub>-norm can avoid over-fitting and eliminate some unattached disease pairs [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. We also use Gaussian interaction profile kernel similarity to get the network similarity of miRNAs and the network similarity of diseases. Therefore, the final prediction accuracy is greatly improved. Meanwhile, 5-fold cross validation is used to evaluate our experimental results. Our proposed method is superior to other methods. In addition, a simulation experiment is conducted to predict novel associations.</p>
  </sec>
  <sec id="Sec2">
    <title>Materials</title>
    <sec id="Sec3">
      <title>MDAs dataset</title>
      <p id="Par14">The information about associations between miRNA and disease is obtained from HMDD [<xref ref-type="bibr" rid="CR42">42</xref>], including 383 diseases, 495 miRNAs and 5430 experimentally confirmed human miRNA-diseases associations. And it is a Gold Standard Dataset. The dataset contains three matrices: <bold>Y</bold> ∈ <italic>ℝ</italic><sup><italic>n</italic> × <italic>m</italic></sup>, <bold>S</bold><sub>m</sub> ∈ <italic>ℝ</italic><sup><italic>n</italic> × <italic>n</italic></sup> and <bold>S</bold><sub><italic>d</italic></sub> ∈ <italic>ℝ</italic><sup><italic>m</italic> × <italic>m</italic></sup>. In addition, <bold>Y</bold> is an adjacency matrix. In the adjacency matrix, there are <italic>n</italic> miRNAs as rows and <italic>m</italic> diseases as columns. If miRNA <italic>D</italic>(<italic>i</italic>) is associated with disease <italic>d</italic>(<italic>j</italic>), the entity <bold>Y</bold>(<italic>D</italic>(<italic>i</italic>), <italic>d</italic>(<italic>j</italic>)) is 1, otherwise 0. The matrix <bold>Y</bold> is used as the original input matrix. <bold>Y</bold> is decomposed into two latent feature matrices, and the product of the two latent feature matrices is used to approximate <bold>Y</bold>. Table <xref rid="Tab1" ref-type="table">1</xref> lists the specific information for the dataset.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>MiRNAs, Diseases, and Associations in Gold Standard Dataset</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Datasets</th><th>MiRNAs</th><th>Diseases</th><th>Associations</th></tr></thead><tbody><tr><td>Gold Standard Dataset</td><td char="." align="char">495</td><td char="." align="char">383</td><td char="." align="char">5430</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec4">
      <title>MiRNA functional similarity</title>
      <p id="Par15">Considering the assumption that similarly functioning miRNAs have similar diseases, Wang <italic>et.al</italic>. proposed a method for calculating the similarity scores of RNA functions [<xref ref-type="bibr" rid="CR26">26</xref>]. And the miRNA functional similarity scores are downloaded from http:// <ext-link ext-link-type="uri" xlink:href="http://www.cuilab.cn/files/images/cuilab/misim.zip">www.cuilab.cn/files/images/cuilab/misim.zip</ext-link>. The matrix <bold>S</bold><sub>m</sub> is represented miRNA function similarity network. The functional similarity score between miRNA <italic>m</italic>(<italic>i</italic>) and <italic>m</italic>(<italic>j</italic>) can be represented <bold>S</bold><sub>m</sub>(<italic>m</italic>(<italic>i</italic>), <italic>m</italic>(<italic>j</italic>)). The <bold>S</bold><sub>m</sub> matrix is also used as an input matrix, which represents the functional similarity of miRNA pairs. Among them, each miRNA has a similarity score of 1 to itself.</p>
    </sec>
    <sec id="Sec5">
      <title>Disease semantic similarity</title>
      <p id="Par16">In this work, Directed Acyclic Graph (DAG) is used to describe the diseases. DAG(<italic>DD</italic>) = (<italic>d</italic>, <italic>T</italic>(<italic>DD</italic>), <italic>E</italic>(<italic>DD</italic>)) is used to describe disease <italic>DD</italic>, where <italic>T</italic>(<italic>DD</italic>) is the node set and <italic>E</italic>(<italic>DD</italic>) is the corresponding links set [<xref ref-type="bibr" rid="CR26">26</xref>]. <bold>S</bold><sub>d</sub> is represented disease semantic similarity network. The semantic value of disease <italic>DD</italic> in DAG(<italic>DD</italic>) formula is defined as:
<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ DV1(DD)=\sum \limits_{d\in T(DD)}D{1}_{DD}(d), $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mi mathvariant="italic">DV</mml:mi><mml:mn>1</mml:mn><mml:mfenced close=")" open="("><mml:mi mathvariant="italic">DD</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>d</mml:mi><mml:mo>∈</mml:mo><mml:mi>T</mml:mi><mml:mfenced close=")" open="("><mml:mi mathvariant="italic">DD</mml:mi></mml:mfenced></mml:mrow></mml:munder><mml:mi>D</mml:mi><mml:msub><mml:mn>1</mml:mn><mml:mi mathvariant="italic">DD</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mi>d</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3260_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ D{1}_{D\mathrm{D}}(d)=\Big\{{\displaystyle \begin{array}{l}1\kern15.30002em if\kern0.3em d= DD\kern0.1em \\ {}\max \left\{\varDelta \ast D{1}_{DD}\left({d}^{\hbox{'}}\right)|{d}^{\hbox{'}}\in childrenof\kern0.1em d\right\}\kern0.5em if\kern0.3em d\ne DD,\end{array}} $$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mi>D</mml:mi><mml:msub><mml:mn>1</mml:mn><mml:mrow><mml:mi>D</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>d</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mo stretchy="true">{</mml:mo><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:mn>1</mml:mn><mml:mspace width="15.30002em"/><mml:mtext mathvariant="italic">if</mml:mtext><mml:mspace width="0.3em"/><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="italic">DD</mml:mi><mml:mspace width="0.1em"/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>max</mml:mo><mml:mfenced close="}" open="{" separators="|"><mml:mrow><mml:mi>Δ</mml:mi><mml:mo>∗</mml:mo><mml:mi>D</mml:mi><mml:msub><mml:mn>1</mml:mn><mml:mi mathvariant="italic">DD</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msup><mml:mi>d</mml:mi><mml:mo>'</mml:mo></mml:msup></mml:mfenced></mml:mrow><mml:mrow><mml:msup><mml:mi>d</mml:mi><mml:mo>'</mml:mo></mml:msup><mml:mo>∈</mml:mo><mml:mtext mathvariant="italic">childrenof</mml:mtext><mml:mspace width="0.1em"/><mml:mi>d</mml:mi></mml:mrow></mml:mfenced><mml:mspace width="0.5em"/><mml:mtext mathvariant="italic">if</mml:mtext><mml:mspace width="0.3em"/><mml:mi>d</mml:mi><mml:mo>≠</mml:mo><mml:mi mathvariant="italic">DD</mml:mi><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="12859_2019_3260_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>where <italic>Δ</italic> is represented the semantic contribution factor. Generally, the semantic contribution of disease <italic>DD</italic> to itself is 1. Based on previous research [<xref ref-type="bibr" rid="CR43">43</xref>], we set <italic>Δ</italic> to 0.5. It is worth noting that the further the distance between <italic>DD</italic> and other disease, the smaller the semantic contribution score. Therefore, disease terms contribute the same score to the semantic value of the disease <italic>DD</italic> in the same layer. Finally, if the two diseases <italic>d</italic>(<italic>i</italic>) and <italic>d</italic>(<italic>j</italic>) have a larger common part of the DAGs, then the two diseases have a greater similarity score. The disease semantic similarity can be defined as follows:
<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\mathbf{S}}_{\mathrm{d}}\left(d(i),d(j)\right)=\frac{\sum_{t\in T\left(d(i)\right)\cap T\left(d(j)\right)}\left(D{1}_{d(i)}(t)+D{1}_{d(j)}(t)\right)}{DV1\left(d(i)\right)+ DV1\left(d(j)\right)}, $$\end{document}</tex-math><mml:math id="M6" display="block"><mml:msub><mml:mi mathvariant="bold">S</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:msub><mml:mfenced close=")" open="(" separators=","><mml:mrow><mml:mi>d</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mfenced close=")" open="("><mml:mi>j</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>∈</mml:mo><mml:mi>T</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi>d</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>∩</mml:mo><mml:mi>T</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi>d</mml:mi><mml:mfenced close=")" open="("><mml:mi>j</mml:mi></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mi>D</mml:mi><mml:msub><mml:mn>1</mml:mn><mml:mrow><mml:mi>d</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi>D</mml:mi><mml:msub><mml:mn>1</mml:mn><mml:mrow><mml:mi>d</mml:mi><mml:mfenced close=")" open="("><mml:mi>j</mml:mi></mml:mfenced></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant="italic">DV</mml:mi><mml:mn>1</mml:mn><mml:mfenced close=")" open="("><mml:mrow><mml:mi>d</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant="italic">DV</mml:mi><mml:mn>1</mml:mn><mml:mfenced close=")" open="("><mml:mrow><mml:mi>d</mml:mi><mml:mfenced close=")" open="("><mml:mi>j</mml:mi></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3260_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>where <bold>S</bold><sub>d</sub> is the disease semantic similarity matrix. In addition, the <bold>S</bold><sub>d</sub> matrix is also used as an input matrix with <bold>Y</bold> and <bold>S</bold><sub>m</sub>. Similar to the <bold>S</bold><sub>m</sub> matrix, each disease has its own semantic similarity score of 1. Therefore, the two feature matrices decomposed by <bold>Y</bold> are controlled by the <bold>S</bold><sub>m</sub> matrix and the <bold>S</bold><sub>d</sub> matrix.</p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Methodology</title>
    <sec id="Sec7">
      <title>Problem formalization</title>
      <p id="Par17">Formally, the known associations <bold>Y</bold>(<italic>m</italic>(<italic>i</italic>), <italic>d</italic>(<italic>j</italic>)) of miRNA <italic>m</italic>(<italic>i</italic>) associated with disease <italic>d</italic>(<italic>j</italic>) are considered to be a matrix factorization model. First, the input associations matrix <bold>Y</bold> is decomposed into two low rank latent feature matrices <bold>A</bold> (for miRNAs) and <bold>B</bold> (for diseases). Then, some constraints are added to the two low rank matrices [<xref ref-type="bibr" rid="CR44">44</xref>]. Specifically, the L<sub>2,1</sub>-norm is added to the latent feature matrix <bold>B</bold> (for diseases). Finally, the specific matrices of <bold>A</bold> and <bold>B</bold> are obtained by using some update rules. It is worth noting that we need a prediction matrix that is derived from the product of <bold>A</bold> and <bold>B</bold>. Considering the stronger association of miRNAs with diseases, the correlation score between them is higher. So, the miRNA-disease pairs <bold>Y</bold>(<italic>m</italic>(<italic>i</italic>), <italic>d</italic>(<italic>j</italic>)) are ranked from high to low.</p>
    </sec>
    <sec id="Sec8">
      <title>Robust collaborative matrix factorization (RCMF)</title>
      <p id="Par18">The traditional CMF is an effective method for predicting novel MDAs [<xref ref-type="bibr" rid="CR10">10</xref>]. Collaborative filtering is used by CMF. The objective function of CMF is given as follows:
<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\displaystyle \begin{array}{l}{\min}_{\mathbf{A},\mathbf{B}}={\left\Vert \mathbf{Y}-\mathbf{A}{\mathbf{B}}^T\right\Vert}_F^2+{\lambda}_l\left({\left\Vert \mathbf{A}\right\Vert}_F^2+{\left\Vert \mathbf{B}\right\Vert}_F^2\right)\\ {}+{\lambda}_d{\left\Vert {\mathbf{S}}_m-\mathbf{A}{\mathbf{A}}^{\mathrm{T}}\right\Vert}_F^2+{\lambda}_t{\left\Vert {\mathbf{S}}_{\mathrm{d}}-\mathbf{B}{\mathbf{B}}^T\right\Vert}_F^2,\end{array}} $$\end{document}</tex-math><mml:math id="M8" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mo>min</mml:mo><mml:mrow><mml:mi mathvariant="bold">A</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold">B</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:mi mathvariant="bold">Y</mml:mi><mml:mo>−</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mi>T</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mi mathvariant="bold">A</mml:mi></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mi mathvariant="bold">B</mml:mi></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:msub><mml:mi mathvariant="bold">S</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:msub><mml:mi mathvariant="bold">S</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mi mathvariant="bold">B</mml:mi><mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mi>T</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="12859_2019_3260_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>where ‖⋅‖<sub><italic>F</italic></sub> is Frobenius norm, <italic>λ</italic><sub><italic>l</italic></sub>, <italic>λ</italic><sub><italic>d</italic></sub> and <italic>λ</italic><sub><italic>t</italic></sub> are non-negative parameters.</p>
      <p id="Par19">However, although the <bold>B</bold> matrix is a low rank matrix, it is not sparse enough. In fact, <bold>B</bold> is indeed sparse. But we want to get the <bold>B</bold> matrix better, we use the L<sub>2,1</sub>-norm to constrain the latent feature matrix <bold>B</bold> of the disease. Because the L<sub>2,1</sub>-norm can achieve row sparse, the L<sub>2,1</sub>-norm can better remove the meaningless elements of the <bold>B</bold> matrix. For matrix <bold>B</bold>, overfitting problems may be generated to reduce the accuracy of the prediction in predicting novel MDAs.</p>
      <p id="Par20">Therefore, to overcome this problem, a robust collaborative matrix factorization method named RCMF is proposed to predict MDAs. The L<sub>2,1</sub>-norm is introduced to the RCMF method to solve over-fitting problems [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. In this paper, the dataset used in the experiment, the number of diseases is less than the number of miRNAs, we are more concerned about which miRNAs are likely to be associated with the diseases. Therefore, we apply the L<sub>2,1</sub>-norm on the potential feature matrix <bold>B</bold> of the disease to make the <bold>B</bold> matrix sparse. The advantage is that more miRNAs can be accurately matched to the disease to improve the accuracy of prediction. The interaction matrix <bold>Y</bold> is decomposed into two matrices <bold>A</bold> and <bold>B</bold>, where <bold>AB</bold><sup><italic>T</italic></sup> ≈ <bold>Y</bold>. RCMF uses two collaborative regularization terms to constrain <bold>A</bold> and <bold>B</bold>. Specifically, these two regularization terms require similar miRNAs or diseases potential feature vectors to be similar, and dissimilar miRNAs or diseases potential feature vectors are not similar, respectively [<xref ref-type="bibr" rid="CR38">38</xref>]. Where <bold>S</bold><sub>m</sub> ≈ <bold>AA</bold><sup><italic>T</italic></sup> and <bold>S</bold><sub>d</sub> ≈ <bold>BB</bold><sup><italic>T</italic></sup>. Therefore, the objective function of RCMF can be written as:
<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\displaystyle \begin{array}{l}{\min}_{\mathbf{A},\mathbf{B}}={\left\Vert \mathbf{Y}-\mathbf{A}{\mathbf{B}}^{\mathrm{T}}\right\Vert}_F^2+{\lambda}_l\left({\left\Vert \mathbf{A}\right\Vert}_F^2+{\left\Vert \mathbf{B}\right\Vert}_F^2\right)+{\lambda}_l{\left\Vert \mathbf{B}\right\Vert}_{2,1}\\ {}+{\lambda}_d{\left\Vert {\mathbf{S}}_{\mathrm{m}}-\mathbf{A}{\mathbf{A}}^{\mathrm{T}}\right\Vert}_F^2+{\lambda}_t{\left\Vert {\mathbf{S}}_{\mathrm{d}}-\mathbf{B}{\mathbf{B}}^{\mathrm{T}}\right\Vert}_F^2,\end{array}} $$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mo>min</mml:mo><mml:mrow><mml:mi mathvariant="bold">A</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold">B</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:mi mathvariant="bold">Y</mml:mi><mml:mo>−</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mi mathvariant="bold">A</mml:mi></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mi mathvariant="bold">B</mml:mi></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:msub><mml:mfenced close="‖" open="‖"><mml:mi mathvariant="bold">B</mml:mi></mml:mfenced><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:msub><mml:mi mathvariant="bold">S</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msubsup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:msub><mml:mi mathvariant="bold">S</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mi mathvariant="bold">B</mml:mi><mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mi>F</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="12859_2019_3260_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>where ‖⋅‖<sub><italic>F</italic></sub> is Frobenius norm, ‖⋅‖<sub>2, 1</sub> is L<sub>2,1</sub>-norm, <italic>λ</italic><sub><italic>l</italic></sub>, <italic>λ</italic><sub><italic>d</italic></sub> and <italic>λ</italic><sub><italic>t</italic></sub> are non-negative parameters. Based on previous research [<xref ref-type="bibr" rid="CR38">38</xref>], the grid search method is used to perform the selection of optimal parameters, where <italic>λ</italic><sub><italic>l</italic></sub> ∈ {2<sup>−2</sup>, 2<sup>−1</sup>, 2<sup>0</sup>, 2<sup>1</sup>} and <italic>λ</italic><sub><italic>d</italic></sub>/<italic>λ</italic><sub><italic>d</italic></sub> ∈ {0, 10<sup>−4</sup>, 10<sup>−3</sup>, 10<sup>−2</sup>, 10<sup>−1</sup>}. In order to find the latent feature matrices <bold>A</bold> and <bold>B</bold>, an approximate model of the matrix <bold>Y</bold> is constructed in the first term. In the second term, the Tikhonov regularization can minimize the norms of <bold>A</bold>, <bold>B</bold>. The L<sub>2,1</sub>-norm is applied on <bold>B</bold> in the third term. And this advantage is able to increase the sparsity of the disease matrix and eliminate undesired disease pairs. The last two regularization terms represent the minimization of squared error between <bold>S</bold><sub>m</sub> (<bold>S</bold><sub>d</sub>) and <bold>AA</bold><sup><italic>T</italic></sup> (<bold>BB</bold><sup><italic>T</italic></sup>).</p>
      <sec id="Sec9">
        <title>Initialization of <bold>A</bold> and <bold>B</bold></title>
        <p id="Par21"><bold>A</bold> and <bold>B</bold> are initialized to use the SVD (Singular Value Decomposition) method for the input MDAs matrix <bold>Y</bold>. The initialization formula can be written as:
<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left[\mathbf{U},\mathbf{S},\mathbf{V}\right]=\mathrm{SVD}\left(\mathbf{Y},k\right),\mathbf{A}=\mathbf{U}{\mathbf{S}}_k^{1/2},\mathbf{B}=\mathbf{V}{\mathbf{S}}_k^{1/2}, $$\end{document}</tex-math><mml:math id="M12" display="block"><mml:mfenced close="]" open="[" separators=",,"><mml:mi mathvariant="bold">U</mml:mi><mml:mi mathvariant="bold">S</mml:mi><mml:mi mathvariant="bold">V</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>SVD</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi mathvariant="bold">Y</mml:mi><mml:mi>k</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="bold">U</mml:mi><mml:msubsup><mml:mi mathvariant="bold">S</mml:mi><mml:mi>k</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="bold">B</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="bold">V</mml:mi><mml:msubsup><mml:mi mathvariant="bold">S</mml:mi><mml:mi>k</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3260_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>where <bold>S</bold><sub><italic>k</italic></sub> is a diagonal matrix, which contains the <italic>k</italic> largest singular values.</p>
      </sec>
      <sec id="Sec10">
        <title>Optimization algorithm</title>
        <p id="Par22"><bold>A</bold> and <bold>B</bold> are updated using least squares in this study. First, <italic>F</italic> is represented as the objection function of RCMF method. Then, <italic>∂F</italic>/<italic>∂</italic><bold>A</bold> and <italic>∂F</italic>/<italic>∂</italic><bold>B</bold> are set to be 0, respectively. <bold>A</bold> and <bold>B</bold> are continued to use the least squares until convergence. Figure <xref rid="Fig1" ref-type="fig">1</xref> shows the convergence of the RCMF method. We perform the RCMF method on the dataset used in the experiment, where the x-axis represents the number of iterations and the y-axis represents the error. As can be seen from Fig. <xref rid="Fig1" ref-type="fig">1</xref>, after 50 iterations, the curve begins to converge on a straight line, which proves that our method begins to converge after 50 iterations. In addition, <italic>λ</italic><sub><italic>l</italic></sub>, <italic>λ</italic><sub><italic>d</italic></sub> and <italic>λ</italic><sub><italic>t</italic></sub> are automatically determined. The optimal parameter values are obtained when cross validating the training set. The update rules of <bold>A</bold> and <bold>B</bold> can be written as:
<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathbf{A}=\left(\mathbf{YB}+{\lambda}_d{\mathbf{S}}_{\mathrm{m}}\mathbf{A}\right){\left({\mathbf{B}}^{\mathrm{T}}\mathbf{B}+{\lambda}_l{\mathbf{I}}_{\mathrm{k}}+{\lambda}_d\mathbf{A}{\mathbf{A}}^{\mathrm{T}}\right)}^{-1}, $$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mi mathvariant="bold">A</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold">YB</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">S</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:msub><mml:mi mathvariant="bold">A</mml:mi></mml:mrow></mml:mfenced><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">I</mml:mi><mml:mi mathvariant="normal">k</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mi mathvariant="bold">A</mml:mi><mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3260_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathbf{B}=\left({\mathbf{Y}}^{\mathrm{T}}\mathbf{A}+{\lambda}_t{\mathbf{S}}_{\mathrm{d}}\mathbf{B}\right){\left({\mathbf{A}}^{\mathrm{T}}\mathbf{A}+{\lambda}_l{\mathbf{I}}_{\mathrm{k}}+{\lambda}_t{\mathbf{B}}^{\mathrm{T}}\mathbf{B}+{\lambda}_l\mathbf{D}{\mathbf{I}}_{\mathrm{k}}\right)}^{-1}, $$\end{document}</tex-math><mml:math id="M16" display="block"><mml:mi mathvariant="bold">B</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi mathvariant="bold">Y</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">S</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:msub><mml:mi mathvariant="bold">B</mml:mi></mml:mrow></mml:mfenced><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">I</mml:mi><mml:mi mathvariant="normal">k</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mi mathvariant="bold">D</mml:mi><mml:msub><mml:mi mathvariant="bold">I</mml:mi><mml:mi mathvariant="normal">k</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3260_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula>where <bold>D</bold> is a diagonal matrix with the <italic>i</italic>-th diagonal element as <italic>d</italic><sub><italic>ii</italic></sub> = 1/2‖(<bold>B</bold>)<sup><italic>i</italic></sup>‖<sub>2</sub>. Based on these update rules, we first calculate the maximum time complexity required to perform the iterative steps, and then we conclude that the final time complexity of RCMF method is <italic>O</italic>(<italic>nmk</italic>), where <italic>n</italic> is the number of miRNAs, <italic>m</italic> is the number of diseases and <italic>k</italic> is the number of singular values in the SVD. Therefore, the algorithm of RCMF is as follows:
<fig id="Fig1"><label>Fig. 1</label><caption><p>Convergence analysis of RCMF method</p></caption><graphic xlink:href="12859_2019_3260_Fig1_HTML" id="MO1"/></fig></p>
        <graphic position="anchor" xlink:href="12859_2019_3260_Figa_HTML" id="MO2"/>
      </sec>
    </sec>
  </sec>
  <sec id="Sec11">
    <title>Results</title>
    <sec id="Sec12">
      <title>Cross validation experiments</title>
      <p id="Par23">In this study, our experiments are compared to the previous advanced methods CMF [<xref ref-type="bibr" rid="CR10">10</xref>], HDMP [<xref ref-type="bibr" rid="CR33">33</xref>], WBSMDA [<xref ref-type="bibr" rid="CR47">47</xref>], MKRMDA [<xref ref-type="bibr" rid="CR31">31</xref>], HAMDA [<xref ref-type="bibr" rid="CR48">48</xref>] and ELLPMDA [<xref ref-type="bibr" rid="CR36">36</xref>]. For each method, 5-fold cross validation is conducted 100 times. However, the WKNKN pre-processing steps is performed before running our method. This can solve the problem of missing unknown values. At the same time, it can also improve the accuracy of prediction to some extent.</p>
      <p id="Par24">In general, AUC (Area Under the Curve) is used as a reasonable indicator when evaluating the predictive performance of a method. The popular indicator of AUC is also used to evaluate our approach in this study. The area under the ROC (Receiver Operating Characteristic) curve is considered to be AUC. In other words, the value of this area will not be greater than 1. AUC values between 0.5 and 1 are normal and reasonable. Once below 0.5, the method will have no meaning at all. Before running cross validation, the miRNA-disease pairs are randomly removed in the input MDAs matrix <bold>Y</bold>. Doing this is a comprehensive assessment of our approach by increasing the difficulty of prediction [<xref ref-type="bibr" rid="CR49">49</xref>]. This way is called CV-p (Cross Validation pairs).</p>
      <sec id="Sec13">
        <title>Association prediction under CV-p</title>
        <p id="Par25">Table <xref rid="Tab2" ref-type="table">2</xref> lists the experimental results at CV-p. The AUC average of 100 times 5-fold cross validation is used as the final AUC score. It is worth noting that AUC is known to be insensitive to skewed class distributions [<xref ref-type="bibr" rid="CR50">50</xref>]. The gold standard miRNA disease dataset is highly unbalanced in this study. One problem is that there are more negative factors than positive ones. Thus, AUC is a more suitable measure for other methods. As shown in Table <xref rid="Tab2" ref-type="table">2</xref>, the AUC values for each method are counted, including the highest AUC in bold, and standard deviations are given in (parentheses).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>AUC Results of cross validation experiments</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Methods</th><th>Gold Standard Dataset</th></tr></thead><tbody><tr><td>WBSMDA</td><td>0.8185(0.0009)</td></tr><tr><td>HDMP</td><td>0.8342(0.0010)</td></tr><tr><td>CMF</td><td>0.8697(0.0011)</td></tr><tr><td>MKRMDA</td><td>0.8894(0.0015)</td></tr><tr><td>HAMDA</td><td>0.8965 (0.0012)</td></tr><tr><td>ELLPMDA</td><td>0.9193(0.0002)</td></tr><tr><td>RCMF</td><td>0.9345(0.0004)</td></tr></tbody></table></table-wrap></p>
        <p id="Par26">As listed in Table <xref rid="Tab2" ref-type="table">2</xref>, our proposed method RCMF achieves an AUC of 0.9345 on Gold Standard Dataset, which is 1.52% higher than ELLPMDA with an AUC of 0.9193. The AUC value of the WBSMDA method is the lowest, and our method is 11.6% higher than it. Also, our method is 6.48% higher than the traditional CMF method. Therefore, our proposed is better than other existing methods. Figure <xref rid="Fig2" ref-type="fig">2</xref> visually shows the AUC level of each method.
<fig id="Fig2"><label>Fig. 2</label><caption><p>AUC value on Gold Standard Dataset</p></caption><graphic xlink:href="12859_2019_3260_Fig2_HTML" id="MO3"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Comprehensive prediction for novel MDAs</title>
      <p id="Par27">A simulation experiment is conducted in this subsection. Two cases are tested by our method, one is Esophageal Neoplasms, the other is Liver Neoplasms. Esophageal Neoplasms is very common in many areas of China, especially in northern China [<xref ref-type="bibr" rid="CR51">51</xref>].. More information about the disease are published in <ext-link ext-link-type="uri" xlink:href="http://www.omim.org/entry/133239">http://www.omim.org/entry/133239</ext-link>. For Esophageal Neoplasms, the 30 miRNAs associated with it are removed. Then, the simulation is conducted to get the final prediction score matrix. Based on the predicted scores for this disease, the miRNAs associated with this disease are ranked from high to low. At the same time, whether the removed miRNA is successfully predicted and the novel associations are also needs to be counted. Twenty known associations are successfully predicted and five novel associations are predicted. Among the unknown associations, the three of five unknown associations are confirmed by the dbDEMC [<xref ref-type="bibr" rid="CR52">52</xref>]. It is worth noting that hsa-mir-215 has the highest correlation with Esophageal Neoplasms. About hsa-mir-215, Fassan et al. have discovered this miRNA in 2011 related to Esophageal Neoplasms. They performed qRT-PCR and ISH analyses on two independent series of endoscopic biopsies (qRT-PCR) and esophagectomy specimens (ISH) [<xref ref-type="bibr" rid="CR53">53</xref>]. In particular, hsa-mir-215 is significantly overexpressed during the pathogenesis of Esophageal Neoplasms. About hsa-mir-184, Kojima et al. discovered this miRNA in 2015 related to Esophageal Neoplasms. They conducted miRNA expression analysis by microarray [<xref ref-type="bibr" rid="CR54">54</xref>]. By comparing Esophageal Neoplasms with normal samples, hsa-mir-184 is under-expressed in diseased samples. Table <xref rid="Tab3" ref-type="table">3</xref> lists the experimental results. And the known associations are in bold.
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Predicted MiRNAs for Esophageal Neoplasms</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Rank</th><th>miRNA</th><th>Evidence</th><th>Rank</th><th>miRNA</th><th>Evidence</th></tr></thead><tbody><tr><td>1</td><td>hsa-let-7a</td><td>known</td><td>16</td><td>hsa-mir-145</td><td>known</td></tr><tr><td>2</td><td>hsa-mir-100</td><td>known</td><td>17</td><td>hsa-mir-146a</td><td>known</td></tr><tr><td>3</td><td>hsa-mir-130a</td><td>known</td><td>18</td><td>hsa-mir-148a</td><td>known</td></tr><tr><td>4</td><td>hsa-let-7c</td><td>known</td><td>19</td><td>hsa-mir-617</td><td>known</td></tr><tr><td>5</td><td>hsa-mir-192</td><td>known</td><td>20</td><td>hsa-mir-758</td><td>known</td></tr><tr><td>6</td><td>hsa-mir-19a</td><td>known</td><td>21</td><td>hsa-mir-342</td><td>known</td></tr><tr><td>7</td><td>hsa-mir-21</td><td>known</td><td>22</td><td>hsa-mir-34a</td><td>known</td></tr><tr><td>8</td><td>hsa-mir-150</td><td>known</td><td>23</td><td>hsa-mir-34b</td><td>known</td></tr><tr><td>9</td><td>hsa-mir-205</td><td>known</td><td>24</td><td>hsa-mir-296</td><td>known</td></tr><tr><td>10</td><td>hsa-mir-22</td><td>known</td><td>25</td><td>hsa-mir-29c</td><td>known</td></tr><tr><td>11</td><td>hsa-mir-223</td><td>known</td><td>26</td><td>hsa-mir-215</td><td>dbDEMC</td></tr><tr><td>12</td><td>hsa-mir-25</td><td>known</td><td>27</td><td>hsa-mir-421</td><td>dbDEMC</td></tr><tr><td>13</td><td>hsa-mir-26a</td><td>known</td><td>28</td><td>hsa-mir-184</td><td>dbDEMC</td></tr><tr><td>14</td><td>hsa-mir-27a</td><td>known</td><td>29</td><td>hsa-mir-519a</td><td>Unconfirmed</td></tr><tr><td>15</td><td>hsa-mir-28</td><td>known</td><td>30</td><td>hsa-mir-610</td><td>Unconfirmed</td></tr></tbody></table></table-wrap></p>
      <p id="Par28">Another case is Liver Neoplasms. It is the fifth most common cancer and the third most common cause of death from cancer worldwide [<xref ref-type="bibr" rid="CR55">55</xref>]. More information about the disease are published in <ext-link ext-link-type="uri" xlink:href="http://www.omim.org/entry/114550">http://www.omim.org/entry/114550</ext-link>. For Liver Neoplasms, fifteen miRNAs associated with it are removed from the dataset while running our method. Then based on the predicted scores for this disease, the miRNAs associated with this disease are ranked from high to low. Finally, twelve known associations are successfully predicted. At the same time, three novel associations are predicted. And, all three are confirmed by dbDEMC. About hsa-mir-200b, hsa-mir-15b and hsa-mir-183, Naoki et al. have discovered this miRNA in 2012 related to Liver Neoplasms. In particular, hsa-mir-200b, hsa-mir-15b,and hsa-mir-183 are significantly overexpressed during the pathogenesis of Liver Neoplasms [<xref ref-type="bibr" rid="CR56">56</xref>]. Table <xref rid="Tab4" ref-type="table">4</xref> lists the experimental results.
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Predicted MiRNAs for Liver Neoplasms</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Rank</th><th>miRNA</th><th>Evidence</th></tr></thead><tbody><tr><td>1</td><td>hsa-mir-372</td><td>known</td></tr><tr><td>2</td><td>hsa-mir-486</td><td>known</td></tr><tr><td>3</td><td>hsa-mir-10b</td><td>known</td></tr><tr><td>4</td><td>hsa-mir-122</td><td>known</td></tr><tr><td>5</td><td>hsa-mir-133b</td><td>known</td></tr><tr><td>6</td><td>hsa-mir-200a</td><td>known</td></tr><tr><td>7</td><td>hsa-mir-148b</td><td>known</td></tr><tr><td>8</td><td>hsa-mir-21</td><td>known</td></tr><tr><td>9</td><td>hsa-let-7b</td><td>known</td></tr><tr><td>10</td><td>hsa-mir-629</td><td>known</td></tr><tr><td>11</td><td>hsa-mir-24</td><td>known</td></tr><tr><td>12</td><td>hsa-mir-34c</td><td>known</td></tr><tr><td>13</td><td>hsa-mir-200b</td><td>dbDEMC</td></tr><tr><td>14</td><td>hsa-mir-15b</td><td>dbDEMC</td></tr><tr><td>15</td><td>hsa-mir-183</td><td>dbDEMC</td></tr></tbody></table></table-wrap></p>
      <p id="Par29">According to the above simulation results, most known miRNAs are predicted. At the same time, some unknown miRNAs are also confirmed by dbDEMC. Therefore, our method can be used to predict novel MDAs and achieve excellent predictions.</p>
    </sec>
  </sec>
  <sec id="Sec15">
    <title>Discussion</title>
    <sec id="Sec16">
      <title>Sensitivity analysis from WKNKN</title>
      <p id="Par30">As mentioned earlier in this study, there are some missing unknown associations in the matrix <bold>Y</bold>, so WKNKN method is used to minimize the error. <italic>K</italic> represents the number of nearest known neighbors and <italic>p</italic> represents a decay term where <italic>p</italic> ≤ 1. Before running RCMF method, the parameters <italic>K</italic> and <italic>p</italic> will be fixed. The sensitivity analysis of these two parameters is given by Figs. <xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>, respectively. It can be clearly seen from the figures that when <italic>K</italic> = 5, <italic>p</italic> = 0.7, the AUC tends to be stable. Furthermore, to more fully verify the sensitivity of these two parameters to AUC, their joint sensitivity analysis is shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref>.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Sensitivity analysis for <italic>K</italic> under CV-p</p></caption><graphic xlink:href="12859_2019_3260_Fig3_HTML" id="MO4"/></fig>
<fig id="Fig4"><label>Fig. 4</label><caption><p>Sensitivity analysis for <italic>p</italic> under CV-p</p></caption><graphic xlink:href="12859_2019_3260_Fig4_HTML" id="MO5"/></fig>
<fig id="Fig5"><label>Fig. 5</label><caption><p>Joint sensitivity analysis of parameters <italic>K</italic> and <italic>p</italic></p></caption><graphic xlink:href="12859_2019_3260_Fig5_HTML" id="MO6"/></fig></p>
    </sec>
    <sec id="Sec17">
      <title>Robust analysis of our method</title>
      <p id="Par31">The L<sub>2,1</sub>-norm can increase the robustness of the algorithm. This is mainly reflected in the distinction between outliers in the dataset. In this section, we use a simulation dataset of 200 data points to verify the robustness of the algorithm. To illustrate RCMF’s ability to learn a subspace, we apply RCMF on a synthetic dataset composed of 200 two-dimensional data points. It is worth noting that all data points are distributed in a one-dimensional subspace, i.e., a straight line (<italic>y</italic> = <italic>x</italic>). In addition, both RCMF and CMF are applied to the synthetic data set for comparison. Specifically, we add different numbers of noise points to the simulation dataset to compare RCMF and CMF. Figures <xref rid="Fig6" ref-type="fig">6</xref> and <xref rid="Fig7" ref-type="fig">7</xref> show the data distribution of 0 noise points, 20 noise points, 40 noise points, 60 noise points and 80 noise points, respectively. As can be seen from Fig. <xref rid="Fig6" ref-type="fig">6</xref>, both RCMF and CMF remain stable when there are no noise points in the dataset. It can be seen from Fig. <xref rid="Fig7" ref-type="fig">7</xref> that as the noise point increases, the CMF cannot continue to maintain stability but gradually shifts. It is worth noting that RCMF can still maintain the same state as the original data point due to the L<sub>2,1</sub>-norm. Even if the number of noise points is constantly increasing, RCMF is still unaffected by outliers. This proves that RCMF is robust.
<fig id="Fig6"><label>Fig. 6</label><caption><p>Robustness comparison between RCMF and CMF when there are 0 noise points</p></caption><graphic xlink:href="12859_2019_3260_Fig6_HTML" id="MO7"/></fig>
<fig id="Fig7"><label>Fig. 7</label><caption><p>Robustness comparison between RCMF and CMF when there are 20, 40, 60 and 80 noise points, respectively</p></caption><graphic xlink:href="12859_2019_3260_Fig7_HTML" id="MO8"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec18">
    <title>Conclusions</title>
    <p id="Par32">Abnormal expression of miRNA has a crucial impact in the development of complex human diseases. More and more diseases are confirmed by biologists to have a close relationship with miRNAs. In this paper, a novel computational model is proposed to predict MDAs. The most valuable contribution is that the L<sub>2,1</sub>-norm is added to the CMF. AUC value is used as a reliable indicator to evaluate our approach. Meanwhile, the excellent results are generated by our method.</p>
    <p id="Par33">More importantly, WKNKN is used as a pre-processing method. This step plays a crucial role in predicting MDAs. The best predictions are achieved by dealing with missing unknown associations.</p>
    <p id="Par34">In the future, more and more novel MDAs will be predicted and more datasets will be available. At the same time, more valuable MDA information will be published in public databases. In fact, there are many other methods to predict MDAs. RCMF is hoped to be helpful for MDA prediction and relevant miRNA research from the computational biology. In future work, we will continue to study more effective methods to predict novel MDAs.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>AUC</term>
        <def>
          <p id="Par4">Area under the curve</p>
        </def>
      </def-item>
      <def-item>
        <term>CMF</term>
        <def>
          <p id="Par5">Collaborative matrix factorization method</p>
        </def>
      </def-item>
      <def-item>
        <term>CV</term>
        <def>
          <p id="Par6">Cross-validation</p>
        </def>
      </def-item>
      <def-item>
        <term>CV-p</term>
        <def>
          <p id="Par7">Cross validation pairs</p>
        </def>
      </def-item>
      <def-item>
        <term>MDAs</term>
        <def>
          <p id="Par8">MiRNA-disease associations</p>
        </def>
      </def-item>
      <def-item>
        <term>RCMF</term>
        <def>
          <p id="Par9">Robust collaborative matrix factorization method</p>
        </def>
      </def-item>
      <def-item>
        <term>SVD</term>
        <def>
          <p id="Par10">Singular value decomposition</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
    <sec id="FPar1">
      <title>About this supplement</title>
      <p id="Par35">This article has been published as part of <italic>BMC Bioinformatics Volume 20 Supplement 25, 2019: Proceedings of the 2018 International Conference on Intelligent Computing (ICIC 2018) and Intelligent Computing and Biomedical Informatics (ICBI) 2018 conference: bioinformatics.</italic> The full contents of the supplement are available online at <ext-link ext-link-type="uri" xlink:href="https://bmcbioinformatics.biomedcentral.com/articles/supplements/volume-20-supplement-25">https://bmcbioinformatics.biomedcentral.com/articles/supplements/volume-20-supplement-25</ext-link>.</p>
    </sec>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>ZC and JXL jointly contributed to the design of the study. YLG designed and implemented the RCMF method, performed the experiments, and drafted the manuscript. CHZ participated in the design of the study and performed the statistical analysis. JW contributed to the data analysis. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>Publication costs are funded by the NSFC under grant Nos. 61872220, and 61572284; by the Co-Innovation Center for Information Supply &amp; Assurance Technology, Anhui University under grant No. ADXXBZ201704.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The datasets that support the findings of this study are available in <ext-link ext-link-type="uri" xlink:href="https://github.com/cuizhensdws/L21-GRMF">https://github.com/cuizhensdws/L21-GRMF</ext-link>.</p>
  </notes>
  <notes>
    <title>Ethics approval and consent to participate</title>
    <p id="Par36">Not applicable.</p>
  </notes>
  <notes>
    <title>Consent for publication</title>
    <p id="Par37">Not applicable.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par38">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ambros</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>microRNAs: tiny regulators with great potential</article-title>
        <source>Cell</source>
        <year>2001</year>
        <volume>107</volume>
        <issue>7</issue>
        <fpage>823</fpage>
        <lpage>826</lpage>
        <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00616-X</pub-id>
        <?supplied-pmid 11779458?>
        <pub-id pub-id-type="pmid">11779458</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ambros</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>The functions of animal microRNAs</article-title>
        <source>Nature</source>
        <year>2004</year>
        <volume>431</volume>
        <issue>7006</issue>
        <fpage>350</fpage>
        <pub-id pub-id-type="doi">10.1038/nature02871</pub-id>
        <?supplied-pmid 15372042?>
        <pub-id pub-id-type="pmid">15372042</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Ibrahim</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yousri</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Ismail</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>El-Makky</surname>
            <given-names>NM</given-names>
          </name>
        </person-group>
        <source>miRNA and gene expression based cancer classification using self-learning and co-training approaches. arXiv preprint arXiv:14014589</source>
        <year>2014</year>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Katayama</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Maeda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Miyaguchi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nemoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yasen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mizushima</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fukuoka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Arii</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling</article-title>
        <source>Oncol Lett</source>
        <year>2012</year>
        <volume>4</volume>
        <issue>4</issue>
        <fpage>817</fpage>
        <lpage>823</lpage>
        <pub-id pub-id-type="doi">10.3892/ol.2012.810</pub-id>
        <?supplied-pmid 23205106?>
        <pub-id pub-id-type="pmid">23205106</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meister</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tuschl</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Mechanisms of gene silencing by double-stranded RNA</article-title>
        <source>Nature</source>
        <year>2004</year>
        <volume>431</volume>
        <issue>7006</issue>
        <fpage>343</fpage>
        <pub-id pub-id-type="doi">10.1038/nature02873</pub-id>
        <?supplied-pmid 15372041?>
        <pub-id pub-id-type="pmid">15372041</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Deng</surname>
            <given-names>S-P</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
        </person-group>
        <article-title>Mining the bladder cancer-associated genes by an integrated strategy for the construction and analysis of differential co-expression networks</article-title>
        <source>BMC genomics</source>
        <year>2015</year>
        <volume>16</volume>
        <issue>Suppl 3</issue>
        <fpage>S4</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-16-S3-S4</pub-id>
        <?supplied-pmid 25707808?>
        <pub-id pub-id-type="pmid">25707808</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <mixed-citation publication-type="other">Hu Y, Liu J-X, Gao Y-L, Li S-J, Wang J. Differentially expressed genes extracted by the tensor robust principal component analysis (TRPCA) method. Complexity. 2019;2019:1-13.</mixed-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Feinbaum</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Ambros</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>The <italic>C. elegans</italic> heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14</article-title>
        <source>Cell</source>
        <year>1993</year>
        <volume>75</volume>
        <issue>5</issue>
        <fpage>843</fpage>
        <lpage>854</lpage>
        <pub-id pub-id-type="doi">10.1016/0092-8674(93)90529-Y</pub-id>
        <?supplied-pmid 8252621?>
        <pub-id pub-id-type="pmid">8252621</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Reinhart</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Slack</surname>
            <given-names>FJ</given-names>
          </name>
          <name>
            <surname>Basson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pasquinelli</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Bettinger</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Rougvie</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Horvitz</surname>
            <given-names>HR</given-names>
          </name>
          <name>
            <surname>Ruvkun</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>The 21-nucleotide let-7 RNA regulates developmental timing in <italic>Caenorhabditis elegans</italic></article-title>
        <source>Nature</source>
        <year>2000</year>
        <volume>403</volume>
        <issue>6772</issue>
        <fpage>901</fpage>
        <pub-id pub-id-type="doi">10.1038/35002607</pub-id>
        <?supplied-pmid 10706289?>
        <pub-id pub-id-type="pmid">10706289</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <mixed-citation publication-type="other">Shen Z, Zhang Y-H, Han K, Nandi AK, Honig B, Huang D-S. miRNA-disease association prediction with collaborative matrix factorization. Complexity. 2017;2017:1-9.</mixed-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>An analysis of human microRNA and disease associations</article-title>
        <source>PLoS One</source>
        <year>2008</year>
        <volume>3</volume>
        <issue>10</issue>
        <fpage>e3420</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0003420</pub-id>
        <?supplied-pmid 18923704?>
        <pub-id pub-id-type="pmid">18923704</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>Semi-supervised learning for potential human microRNA-disease associations inference</article-title>
        <source>Sci Rep</source>
        <year>2014</year>
        <volume>4</volume>
        <fpage>5501</fpage>
        <pub-id pub-id-type="doi">10.1038/srep05501</pub-id>
        <?supplied-pmid 24975600?>
        <pub-id pub-id-type="pmid">24975600</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bandyopadhyay</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mitra</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Maulik</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>MQ</given-names>
          </name>
        </person-group>
        <article-title>Development of the human cancer microRNA network</article-title>
        <source>Silence</source>
        <year>2010</year>
        <volume>1</volume>
        <issue>1</issue>
        <fpage>6</fpage>
        <pub-id pub-id-type="doi">10.1186/1758-907X-1-6</pub-id>
        <?supplied-pmid 20226080?>
        <pub-id pub-id-type="pmid">20226080</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kozomara</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Griffiths-Jones</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>miRBase: annotating high confidence microRNAs using deep sequencing data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>42</volume>
        <issue>D1</issue>
        <fpage>D68</fpage>
        <lpage>D73</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkt1181</pub-id>
        <?supplied-pmid 24275495?>
        <pub-id pub-id-type="pmid">24275495</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yi</surname>
            <given-names>H-C</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>Z-H</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>T-H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L-P</given-names>
          </name>
        </person-group>
        <article-title>A deep learning framework for robust and accurate prediction of ncRNA-protein interactions using evolutionary information</article-title>
        <source>Mol Ther Nucleic Acids</source>
        <year>2018</year>
        <volume>11</volume>
        <fpage>337</fpage>
        <lpage>344</lpage>
        <pub-id pub-id-type="doi">10.1016/j.omtn.2018.03.001</pub-id>
        <?supplied-pmid 29858068?>
        <pub-id pub-id-type="pmid">29858068</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peng</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
        </person-group>
        <article-title>Discovery of relationships between long non-coding RNAs and genes in human diseases based on tensor completion</article-title>
        <source>IEEE Access</source>
        <year>2018</year>
        <volume>6</volume>
        <fpage>59152</fpage>
        <lpage>59162</lpage>
        <pub-id pub-id-type="doi">10.1109/ACCESS.2018.2873013</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bao</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
        </person-group>
        <article-title>Novel human microbe-disease association prediction using network consistency projection</article-title>
        <source>BMC Bioinformatics</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>16</issue>
        <fpage>543</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-017-1968-2</pub-id>
        <?supplied-pmid 29297304?>
        <pub-id pub-id-type="pmid">29297304</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>C-H</given-names>
          </name>
        </person-group>
        <article-title>Independent component analysis-based penalized discriminant method for tumor classification using gene expression data</article-title>
        <source>Bioinformatics</source>
        <year>2006</year>
        <volume>22</volume>
        <issue>15</issue>
        <fpage>1855</fpage>
        <lpage>1862</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btl190</pub-id>
        <?supplied-pmid 16709589?>
        <pub-id pub-id-type="pmid">16709589</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Ning</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nie</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Down-regulated miR-9 and miR-433 in human gastric carcinoma</article-title>
        <source>J Exp Clin Cancer Res</source>
        <year>2009</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>82</fpage>
        <pub-id pub-id-type="doi">10.1186/1756-9966-28-82</pub-id>
        <?supplied-pmid 19531230?>
        <pub-id pub-id-type="pmid">19531230</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Patel</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hajarnis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pontoglio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Somlo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Igarashi</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>miR-17∼ 92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease</article-title>
        <source>Proc Natl Acad Sci</source>
        <year>2013</year>
        <volume>110</volume>
        <issue>26</issue>
        <fpage>10765</fpage>
        <lpage>10770</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1301693110</pub-id>
        <?supplied-pmid 23759744?>
        <pub-id pub-id-type="pmid">23759744</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>S-S</given-names>
          </name>
        </person-group>
        <source>LncRNA-disease associations prediction using bipartite local model with nearest profile-based association inferring. IEEE journal of biomedical and health informatics</source>
        <year>2019</year>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>C-H</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kong</surname>
            <given-names>X-Z</given-names>
          </name>
        </person-group>
        <article-title>Tumor clustering using nonnegative matrix factorization with gene selection</article-title>
        <source>IEEE Trans Inf Technol Biomed</source>
        <year>2009</year>
        <volume>13</volume>
        <issue>4</issue>
        <fpage>599</fpage>
        <lpage>607</lpage>
        <pub-id pub-id-type="doi">10.1109/TITB.2009.2018115</pub-id>
        <?supplied-pmid 19369170?>
        <pub-id pub-id-type="pmid">19369170</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sethupathy</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>FS</given-names>
          </name>
        </person-group>
        <article-title>MicroRNA target site polymorphisms and human disease</article-title>
        <source>Trends Genet</source>
        <year>2008</year>
        <volume>24</volume>
        <issue>10</issue>
        <fpage>489</fpage>
        <lpage>497</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tig.2008.07.004</pub-id>
        <?supplied-pmid 18778868?>
        <pub-id pub-id-type="pmid">18778868</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xin</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Cabeza</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wrana</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Evidence for positive selection on a number of microRNA regulatory interactions during recent human evolution</article-title>
        <source>PLoS Genet</source>
        <year>2012</year>
        <volume>8</volume>
        <issue>3</issue>
        <fpage>e1002578</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1002578</pub-id>
        <?supplied-pmid 22457636?>
        <pub-id pub-id-type="pmid">22457636</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Shang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>L-Y</given-names>
          </name>
        </person-group>
        <article-title>Co-differential gene selection and clustering based on graph regularized multi-view NMF in cancer genomic data</article-title>
        <source>Genes</source>
        <year>2018</year>
        <volume>9</volume>
        <issue>12</issue>
        <fpage>586</fpage>
        <pub-id pub-id-type="doi">10.3390/genes9120586</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <issue>13</issue>
        <fpage>1644</fpage>
        <lpage>1650</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq241</pub-id>
        <?supplied-pmid 20439255?>
        <pub-id pub-id-type="pmid">20439255</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <mixed-citation publication-type="other">Gao M-M, Cui Z, Gao Y-L, Li F, Liu J-X. Dual Sparse Collaborative Matrix Factorization Method Based on Gaussian Kernel Function for Predicting LncRNA-Disease Associations. In: International Conference on Intelligent Computing. Cham, Springer; 2019. p. 318–26.</mixed-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Juan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Teng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Prioritization of disease microRNAs through a human phenome-microRNAome network</article-title>
        <source>BMC Syst Biol</source>
        <year>2010</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>S2</fpage>
        <pub-id pub-id-type="doi">10.1186/1752-0509-4-S1-S2</pub-id>
        <?supplied-pmid 20522252?>
        <pub-id pub-id-type="pmid">20522252</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>Z-H</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y-A</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>HGIMDA: heterogeneous graph inference for miRNA-disease association prediction</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>40</issue>
        <fpage>65257</fpage>
        <?supplied-pmid 27533456?>
        <pub-id pub-id-type="pmid">27533456</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes</article-title>
        <source>BMC Syst Biol</source>
        <year>2013</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>101</fpage>
        <pub-id pub-id-type="doi">10.1186/1752-0509-7-101</pub-id>
        <?supplied-pmid 24103777?>
        <pub-id pub-id-type="pmid">24103777</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>Y-W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G-H</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>MKRMDA: multiple kernel learning-based Kronecker regularized least squares for MiRNA–disease association prediction</article-title>
        <source>J Transl Med</source>
        <year>2017</year>
        <volume>15</volume>
        <issue>1</issue>
        <fpage>251</fpage>
        <pub-id pub-id-type="doi">10.1186/s12967-017-1340-3</pub-id>
        <?supplied-pmid 29233191?>
        <pub-id pub-id-type="pmid">29233191</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>MX</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>GY</given-names>
          </name>
        </person-group>
        <article-title>RWRMDA: predicting novel human microRNA-disease associations</article-title>
        <source>Mol BioSyst</source>
        <year>2012</year>
        <volume>8</volume>
        <issue>10</issue>
        <fpage>2792</fpage>
        <lpage>2798</lpage>
        <pub-id pub-id-type="doi">10.1039/c2mb25180a</pub-id>
        <?supplied-pmid 22875290?>
        <pub-id pub-id-type="pmid">22875290</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Teng</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors</article-title>
        <source>PLoS One</source>
        <year>2013</year>
        <volume>8</volume>
        <issue>8</issue>
        <fpage>e70204</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0070204</pub-id>
        <?supplied-pmid 23950912?>
        <pub-id pub-id-type="pmid">23950912</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Q-F</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>RKNNMDA: ranking-based KNN for MiRNA-disease association prediction</article-title>
        <source>RNA Biol</source>
        <year>2017</year>
        <volume>14</volume>
        <issue>7</issue>
        <fpage>952</fpage>
        <lpage>962</lpage>
        <pub-id pub-id-type="doi">10.1080/15476286.2017.1312226</pub-id>
        <?supplied-pmid 28421868?>
        <pub-id pub-id-type="pmid">28421868</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>M-M</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>C-H</given-names>
          </name>
        </person-group>
        <article-title>Dual-network sparse graph regularized matrix factorization for predicting miRNA–disease associations</article-title>
        <source>Molecular omics</source>
        <year>2019</year>
        <volume>15</volume>
        <issue>2</issue>
        <fpage>130</fpage>
        <lpage>137</lpage>
        <pub-id pub-id-type="doi">10.1039/C8MO00244D</pub-id>
        <?supplied-pmid 30723850?>
        <pub-id pub-id-type="pmid">30723850</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>ELLPMDA: ensemble learning and link prediction for miRNA-disease association prediction</article-title>
        <source>RNA Biol</source>
        <year>2018</year>
        <volume>15</volume>
        <issue>6</issue>
        <fpage>807</fpage>
        <lpage>818</lpage>
        <?supplied-pmid 29619882?>
        <pub-id pub-id-type="pmid">29619882</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>C-H</given-names>
          </name>
        </person-group>
        <article-title>NPCMF: nearest profile-based collaborative matrix factorization method for predicting miRNA-disease associations</article-title>
        <source>BMC Bioinformatics</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>353</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-019-2956-5</pub-id>
        <?supplied-pmid 31234797?>
        <pub-id pub-id-type="pmid">31234797</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ezzat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X-L</given-names>
          </name>
          <name>
            <surname>Kwoh</surname>
            <given-names>C-K</given-names>
          </name>
        </person-group>
        <article-title>Drug-target interaction prediction with graph regularized matrix factorization</article-title>
        <source>IEEE/ACM Transactions on Computational Biology and Bioinformatics (TCBB)</source>
        <year>2017</year>
        <volume>14</volume>
        <issue>3</issue>
        <fpage>646</fpage>
        <lpage>656</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2016.2530062</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Yin</surname>
            <given-names>M-M</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>M-M</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
        </person-group>
        <source>LWPCMF: logistic weighted profile-based collaborative matrix factorization for predicting MiRNA-disease associations. IEEE/ACM transactions on computational biology and bioinformatics</source>
        <year>2019</year>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>L-Y</given-names>
          </name>
        </person-group>
        <article-title>The computational prediction of drug-disease interactions using the dual-network L 2, 1-CMF method</article-title>
        <source>BMC Bioinformatics</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-018-2575-6</pub-id>
        <?supplied-pmid 30611214?>
        <pub-id pub-id-type="pmid">30611214</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>D-Q</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>C-H</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>S-S</given-names>
          </name>
          <name>
            <surname>Shang</surname>
            <given-names>J-L</given-names>
          </name>
        </person-group>
        <article-title>Identifying drug-pathway association pairs based on L 2, 1-integrative penalized matrix decomposition</article-title>
        <source>BMC Syst Biol</source>
        <year>2017</year>
        <volume>11</volume>
        <issue>6</issue>
        <fpage>119</fpage>
        <pub-id pub-id-type="doi">10.1186/s12918-017-0480-7</pub-id>
        <?supplied-pmid 29297378?>
        <pub-id pub-id-type="pmid">29297378</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Geng</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>HMDD v2. 0: a database for experimentally supported human microRNA and disease associations</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>42</volume>
        <issue>D1</issue>
        <fpage>D1070</fpage>
        <lpage>D1074</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkt1023</pub-id>
        <?supplied-pmid 24194601?>
        <pub-id pub-id-type="pmid">24194601</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Inferring microRNA-disease associations by random walk on a heterogeneous network with multiple data sources</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2017</year>
        <volume>14</volume>
        <issue>4</issue>
        <fpage>905</fpage>
        <lpage>915</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2016.2550432</pub-id>
        <?supplied-pmid 27076459?>
        <pub-id pub-id-type="pmid">27076459</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yuan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>W-L</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
        </person-group>
        <article-title>Nonconvex penalty based low-rank representation and sparse regression for eQTL mapping</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform (TCBB)</source>
        <year>2017</year>
        <volume>14</volume>
        <issue>5</issue>
        <fpage>1154</fpage>
        <lpage>1164</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2016.2609420</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>L-Y</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>S-S</given-names>
          </name>
        </person-group>
        <article-title>L 2, 1-GRMF: an improved graph regularized matrix factorization method to predict drug-target interactions</article-title>
        <source>BMC bioinformatics</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>8</issue>
        <fpage>287</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-019-2768-7</pub-id>
        <?supplied-pmid 31182006?>
        <pub-id pub-id-type="pmid">31182006</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <mixed-citation publication-type="other">Yu N, Gao Y-L, Liu J-X, Wang J, Shang J. Hypergraph regularized NMF by L 2, 1-norm for Clustering and Com-abnormal Expression Genes Selection. In: 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). Madrid;IEEE. 2018;578-82.</mixed-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>Z-H</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>WBSMDA: within and between score for MiRNA-disease association prediction</article-title>
        <source>Sci Rep</source>
        <year>2016</year>
        <volume>6</volume>
        <fpage>21106</fpage>
        <pub-id pub-id-type="doi">10.1038/srep21106</pub-id>
        <?supplied-pmid 26880032?>
        <pub-id pub-id-type="pmid">26880032</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>Y-W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G-H</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>HAMDA: hybrid approach for MiRNA-disease association prediction</article-title>
        <source>J Biomed Inform</source>
        <year>2017</year>
        <volume>76</volume>
        <fpage>50</fpage>
        <lpage>58</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jbi.2017.10.014</pub-id>
        <?supplied-pmid 29097278?>
        <pub-id pub-id-type="pmid">29097278</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <mixed-citation publication-type="other">Ezzat A, Wu M, Li X-L, Kwoh C-K. Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey. Brief Bioinform. 2018;8:1337–57.</mixed-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ezzat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X-L</given-names>
          </name>
          <name>
            <surname>Kwoh</surname>
            <given-names>C-K</given-names>
          </name>
        </person-group>
        <article-title>Drug-target interaction prediction via class imbalance-aware ensemble learning</article-title>
        <source>BMC Bioinformatics</source>
        <year>2016</year>
        <volume>17</volume>
        <issue>19</issue>
        <fpage>509</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-016-1377-y</pub-id>
        <?supplied-pmid 28155697?>
        <pub-id pub-id-type="pmid">28155697</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>L-D</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>F-Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X-M</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L-D</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J-M</given-names>
          </name>
          <name>
            <surname>Kong</surname>
            <given-names>G-Q</given-names>
          </name>
          <name>
            <surname>Qi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1</article-title>
        <source>Nat Genet</source>
        <year>2010</year>
        <volume>42</volume>
        <issue>9</issue>
        <fpage>759</fpage>
        <pub-id pub-id-type="doi">10.1038/ng.648</pub-id>
        <?supplied-pmid 20729853?>
        <pub-id pub-id-type="pmid">20729853</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>dbDEMC: a database of differentially expressed miRNAs in human cancers</article-title>
        <source>BMC Genomics</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>Suppl 4</issue>
        <fpage>S5</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-11-S4-S5</pub-id>
        <?supplied-pmid 21143814?>
        <pub-id pub-id-type="pmid">21143814</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fassan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Volinia</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Palatini</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pizzi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Baffa</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>De Bernard</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Battaglia</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Parente</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Croce</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Zaninotto</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>MicroRNA expression profiling in human Barrett's carcinogenesis</article-title>
        <source>Int J Cancer</source>
        <year>2011</year>
        <volume>129</volume>
        <issue>7</issue>
        <fpage>1661</fpage>
        <lpage>1670</lpage>
        <pub-id pub-id-type="doi">10.1002/ijc.25823</pub-id>
        <?supplied-pmid 21128279?>
        <pub-id pub-id-type="pmid">21128279</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kojima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sudo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kawauchi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Takizawa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kondou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nobumasa</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ochiai</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers</article-title>
        <source>PLoS One</source>
        <year>2015</year>
        <volume>10</volume>
        <issue>2</issue>
        <fpage>e0118220</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0118220</pub-id>
        <?supplied-pmid 25706130?>
        <pub-id pub-id-type="pmid">25706130</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Taniguchi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Aderca</surname>
            <given-names>IN</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Nagorney</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Burgart</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Roche</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>DI</given-names>
          </name>
        </person-group>
        <article-title>Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas</article-title>
        <source>Oncogene</source>
        <year>2002</year>
        <volume>21</volume>
        <issue>31</issue>
        <fpage>4863</fpage>
        <pub-id pub-id-type="doi">10.1038/sj.onc.1205591</pub-id>
        <?supplied-pmid 12101426?>
        <pub-id pub-id-type="pmid">12101426</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oishi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Roessler</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Forgues</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Budhu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Andersen</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>QH</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>HL</given-names>
          </name>
        </person-group>
        <article-title>Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma</article-title>
        <source>Hepatology</source>
        <year>2012</year>
        <volume>56</volume>
        <issue>5</issue>
        <fpage>1792</fpage>
        <lpage>1803</lpage>
        <pub-id pub-id-type="doi">10.1002/hep.25890</pub-id>
        <?supplied-pmid 22707408?>
        <pub-id pub-id-type="pmid">22707408</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
